BioLargo Reports 45% Revenue Decline and Increased Net Loss in Q2 2025

BioLargo, Inc. reported a significant decline in financial performance for the second quarter of 2025, with total revenue of $2.8 million, a decrease of 45% compared to $5.0 million in the same period last year. For the first half of 2025, the company generated $6.0 million in revenue, down from $9.8 million in the first half of 2024. The decline was primarily attributed to reduced sales of its pet odor control product, Pooph, which accounted for 57% of total revenue in the latest quarter, down from 70% a year earlier. The company also reported a net loss of $1.9 million for the quarter, compared to a loss of $780,000 in Q2 2024, and a total net loss of $3.8 million for the first half of 2025, up from $1.6 million in the prior year.

In terms of operational changes, BioLargo's subsidiary ONM Environmental experienced a 50% drop in revenue for the second quarter, largely due to decreased sales of the Pooph product. Conversely, the engineering segment, BLEST, saw a 23% decrease in revenue for the quarter but a 4% increase for the first half of the year, driven by new contracts for air quality control services. The company’s total operating expenses increased to $3.2 million for the quarter, up from $3.0 million in the previous year, with selling, general, and administrative expenses rising by 12% to $2.7 million.

As of June 30, 2025, BioLargo reported current assets of $9.2 million, including $3.5 million in cash and cash equivalents, while current liabilities stood at $4.1 million, resulting in working capital of $5.1 million. The company utilized $3.9 million in cash for operating activities during the first half of the year but received $3.7 million from financing activities, indicating a reliance on external funding to support operations. The company’s employee headcount remained stable at 42 full-time employees.

Looking ahead, BioLargo expressed concerns regarding its ability to sustain operations without additional capital, as it does not expect gross profits for the remainder of 2025 to be sufficient to fund its current operational levels. The company is actively seeking to increase revenues and convert receivables into cash to improve its liquidity position. Management indicated that without successful capital raising efforts or operational improvements, it may need to curtail certain operations. The company’s ongoing projects, including advancements in its PFAS remediation technology and battery development, are seen as potential growth areas, but the timeline for revenue generation from these initiatives remains uncertain.